MDT Stock Analysis — AI Buy/Sell Signals & Forecast

Real-time AI-powered analysis for MDT with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.

Unlock Full Pro Analysis

Real-time alerts, price targets, institutional flow & more — one-time $19.95.

MDT · Medtronic plc

Free summary — full analysis below.

Sell
Price
$87.75
Change
+2.62%
Confidence
50%
Risk
moderate
MDT

Medtronic plc

$87.750+$2.24 (+2.62%)
Live

Pre-Market & After Hours is Pro Only

Upgrade to unlock this and all premium features

Day's Range: $85.55 – $88.47
Refresh in 58s

Oct 9, 11:56 AM

SELL
Confidence Score
50%

Confidence Score is Pro Only

Upgrade to unlock this and all premium features

Optimal Buy & Sell Zones is Pro Only

Upgrade to unlock this and all premium features

🟡 Pre-Market07:56:51 AM ET
Moving Average Trend

Mixed Signals

Total Conviction Scorecard is Pro Only

Upgrade to unlock this and all premium features

Optimal Buy & Sell Zones is Pro Only

Upgrade to unlock this and all premium features

52-Wk High
$106.33

$-18.58 (-17.5%) from high

Current Price — MDT
$87.75

Day's Range: $85.55 – $88.47

52-Wk Low
$73.31

+$14.44 (+19.7%) above low

SMA 50-Day
$90.05

▼ Below — short-term downtrend (bearish)

SMA 200-Day
$88.42

▼ Below — long-term downtrend (bearish)

Today's Volume
105.7M shares

🔥 4.2x avg — unusually busy, big moves more likely

Trader Interest
4.18x normal

🔥 Very high — major news or event driving trades

Technical Indicators (Daily Close)
Updated: Oct 9 @ 11:56 AM

RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.

Price Alerts

Institutional Money Flow is Pro Only

Upgrade to unlock this and all premium features

Phantom Flow is Pro Only

Upgrade to unlock this and all premium features

Smart Money Flow Index is Pro Only

Upgrade to unlock this and all premium features

Risk Score is Pro Only

Upgrade to unlock this and all premium features

BUY
News-Based Signal

Medtronic is positioning itself for long-term growth through significant robotics investments and strategic portfolio restructuring. The company's imminent status as a Dividend King combined with its monopolistic business model makes it an attractive prospect for income-focused investors.

Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.

MDT Stock Analysis — Frequently Asked Questions

Is MDT a buy or sell right now?▾

Our AI engine analyzes MDT across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.

What is the price target for MDT?▾

The analysis calculates optimal entry and exit price targets for MDT using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.

What do the RSI and MACD signals say about MDT?▾

RSI measures whether MDT is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.

Are institutions buying MDT?▾

We track institutional positioning in MDT through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.

What are the main risks of investing in MDT?▾

Key risks for MDT include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.

How accurate is the MDT AI analysis?▾

The MDT analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.

Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.

More in Healthcare & Biotech

Market Intelligence. ETF Intelligence.𝕏 © 2026 ETF Finder. All rights reserved. Content protected by copyright law. Unauthorized scraping, copying, or distribution is prohibited.
Security MonitorProtection: ActiveRisk: LowThreats: 0 BlockedReq/min: 011:56:51 AM · 09-OCT-2026Rate limiting • Bot detection • IP monitoring